KMR-206
KMR-206 is a potent and selective PARP7 inhibitor with an IC50 of 13.7 nM. It enhances the expression of STAT1 and phosphorylated Tyr701 site STAT1 (pSTAT1) . KMR-206 induces STING degradation and elevates type I IFN receptor levels, showing anticancer activity against lung adenocarcinoma and is applicable in colon cancer research.
Product Specifications
CAS Number
2992741-10-1
Smiles
N#CC1=CN=C (C=C1) N2CCN (C (=O) C3=CC (=CC=C3F) CC4=NNC (=O) C=5C=CC (C#CC) =CC54) CC2
Molecular Formula
C29H23FN6O2
Molecular Weight
506.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
123671-ML750 100 µL
ATF6 (Cyclic AMP-dependent Transcription Factor ATF-6 alpha, cAMP-dependent Transcription Factor ATF-6 alpha, Activating Transcription Factor 6 alpha, ATF6-alpha, Processed Cyclic AMP-dependent Transcription Factor ATF-6 alpha) (MaxLight 750) discontinued
Sign In for Pricing
View Details 
043581-PE 200 µL
UGT2B10, CT (UGT2B10, UDP-glucuronosyltransferase 2B10) (PE) discontinued
Sign In for Pricing
View Details MBS6291157-01 0.2 mL
DCP2, ID (DCP2, NUDT20, m7GpppN-mRNA hydrolase, Nucleoside diphosphate-linked moiety X motif 20, mRNA-decapping enzyme 2) (APC)
Sign In for Pricing
View Details